State Street Corp Gritstone Bio, Inc. Transaction History

State Street Corp

$2.25 Trillion
Q2 2024

A detailed history of State Street Corp transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, State Street Corp holds 329,830 shares of GRTS stock, worth $62,667. This represents 0.0% of its overall portfolio holdings.

Number of Shares

329,830

Previous 1,800,275 81.68%

Holding current value

$62,667

Previous $4.63 Million 95.59%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.62 - $2.35 $911,675 - $3.46 Million	-1,470,445 Reduced 81.68%	329,830 $204,000
Q1 2024 May 15, 2024	BUY	$1.96 - $2.9 $37,773 - $55,888	19,272 Added 1.08%	1,800,275 $4.63 Million
Q4 2023 Feb 14, 2024	BUY	$1.28 - $2.85 $236,014 - $525,500	184,386 Added 11.55%	1,781,003 $3.63 Million
Q3 2023 Nov 14, 2023	BUY	$1.19 - $2.26 $100,293 - $190,472	84,280 Added 5.57%	1,596,617 $2.75 Million
Q2 2023 Aug 14, 2023	BUY	$1.66 - $3.03 $2.06 Million - $3.75 Million	1,239,007 Added 453.3%	1,512,337 $2.95 Million
Q1 2023 May 15, 2023	SELL	$2.13 - $3.74 $14,910 - $26,180	-7,000 Reduced 2.5%	273,330 $759,000
Q4 2022 Feb 14, 2023	BUY	$2.17 - $3.92 $166,656 - $301,056	76,800 Added 37.73%	280,330 $967,000
Q3 2022 Nov 15, 2022	SELL	$2.46 - $4.75 $133,578 - $257,925	-54,300 Reduced 21.06%	203,530 $523,000
Q2 2022 Aug 15, 2022	SELL	$1.77 - $4.34 $1.26 Million - $3.09 Million	-712,152 Reduced 73.42%	257,830 $624,000
Q1 2022 May 16, 2022	SELL	$4.03 - $12.19 $10.9 Million - $33 Million	-2,703,797 Reduced 73.6%	969,982 $4 Million
Q4 2021 Feb 14, 2022	BUY	$8.76 - $13.71 $25.5 Million - $39.9 Million	2,912,305 Added 382.46%	3,673,779 $47.2 Million
Q3 2021 Nov 15, 2021	BUY	$6.41 - $13.54 $1.05 Million - $2.22 Million	163,833 Added 27.41%	761,474 $8.22 Million
Q2 2021 Aug 16, 2021	BUY	$8.13 - $10.2 $435,109 - $545,893	53,519 Added 9.84%	597,641 $5.46 Million
Q1 2021 May 17, 2021	BUY	$4.07 - $27.11 $119,006 - $792,696	29,240 Added 5.68%	544,122 $5.13 Million
Q4 2020 Feb 16, 2021	BUY	$2.57 - $4.22 $26,995 - $44,326	10,504 Added 2.08%	514,882 $2.03 Million
Q3 2020 Nov 10, 2020	BUY	$2.63 - $8.09 $28,567 - $87,873	10,862 Added 2.2%	504,378 $1.34 Million
Q2 2020 Aug 14, 2020	BUY	$5.69 - $8.17 $138,858 - $199,380	24,404 Added 5.2%	493,516 $3.28 Million
Q1 2020 May 11, 2020	BUY	$5.47 - $11.3 $2.57 Million - $5.3 Million	469,112 New	469,112 $2.73 Million

Others Institutions Holding GRTS

# of Institutions

Shares Held

37.5M

Call Options Held

1.46M

Put Options Held

168K

View Full List

About Gritstone bio, Inc.

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $13.9M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

More about GRTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Gritstone Bio, Inc. Transaction History